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Abstract
Introduction: Pre-preanalytical and post-postanalytical phases are steps where the laboratory professional may play a crucial role. Measuring the 
serum circulating 25 hydroxyvitamin D level (25(OH)D) is recommended to evaluate vitamin D status in patients at risk for vitamin D deficiency while 
1,25 hydroxyvitamin D (1,25(OH)2D) is only recommended to monitor several particular conditions (chronic kidney disease, hereditary phosphate-
losing disorders, and some other) clearly defined by the current clinical guidelines of Endocrine Society. 
Our research hypothesis was that through education and communication through comments in the Laboratory Information System (LIS), we could 
improve appropriateness in the request vitamin D tests.
Materials and methods: A retrospective observational cross-sectional study was conducted from January 2005 to December 2014. Each 1,25(OH)2D 
request was reviewed individually by a member of the laboratory staff. Starting in November 2011, each inappropriate 1,25(OH)2D request was regi-
stered in LIS and 25(OH)D was measured instead of 1,25(OH)2D. We counted the overall number of 1,25(OH)2D requests and the number of inappro-
priate requests which then were marked with a comment.  
Results: The request of 25(OH)D increased along years. However, 1,25(OH)2D requests increased until 2012 when demand began to diminish.  
Conclusions: Education and communication through comments in the LIS, corrected the inappropriate request of 1,25(OH)2D and promoted the use 
of 25(OH)D to study vitamin D deficiency. 
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The laboratory total testing process begins when 
the clinician considers what test to order accord-
ing to its clinical suspicion, and finishes with inter-
pretation of the results. Although traditionally the 
brain of the requesting clinician has been always 
been part of the Lundberg brain to brain circle (1), 
it was not until recently when the laboratorian’s 
brain was included (2). In fact, nowadays, the labo-
ratory professional should oversee and improve 
the pre-preanalytical and post-postanalytical 
phases.
The measurement of vitamin D status is a peculiar 
case in laboratory medicine. It is well known that 
vitamin D is a hormone precursor that is present in 
two forms: ergocalciferol or vitamin D2 and chole-
calciferol or vitamin D3 that is synthesized from 
7-dehydrocholesterol in the skin by sunlight. Once 
synthesized, the vitamin D binding protein trans-
ports the vitamin D3 to the liver where it is hydrox-
ylated to 25 hydroxyvitamin D (25(OH)D), the inac-
tive form of vitamin D, and then to the kidneys 
where it is again hydroxylated by the enzyme 
Biochemia Medica 2015;25(2):237–41  http://dx.doi.org/10.11613/BM.2015.024 
238
Salinas M. et al. Education and communication to improve the request
1-α-hydroxylase to 1,25 hydroxyvitamin D 
(1,25(OH)2D), its active form. The peculiarity lies in 
the fact that we usually do not evaluate 1,25(OH)2D, 
the active form. In contrast to expectation, the rec-
ommended test to measure vitamin D nutritional 
status, is 25(OH)D, since it is the main circulating 
form, has a long half-life, its concentration varies 
less day-to-day with exposure to sun light and di-
etary intake and its measurement is easier when 
compared to 1,25(OH)2D and can be done by 
means of reliable assay (3).
The 1,25(OH)2D assay should never be used to de-
tect vitamin D deficiency, since its levels may be 
normal or even elevated as a result of secondary hy-
perparathyroidism (3,4). Serum 1,25(OH)2D is only 
recommended to monitor certain conditions, such 
as acquired and inherited disorders in the metabo-
lism of 25(OH)D and phosphate, including chronic 
kidney disease, hereditary phosphate-losing disor-
ders, oncogenic osteomalacia, pseudovitamin D-
deficiency rickets, vitamin D-resistant rickets, as 
well as chronic granuloma forming disorders such 
as sarcoidosis and some lymphomas (4). 
A low vitamin D level is an established risk factor 
for osteoporosis. Vitamin D may be also a determi-
nant factor in mortality due to its anti-inflammato-
ry and immune-modulating effects (5). Further-
more, lower serum 25(OH)D levels are associated 
with prediabetes (6), although the current evi-
dence does not support the notion that vitamin D 
supplementation improves hyperglycemia, beta 
cell secretion or insulin sensitivity in patients with 
type 2 diabetes (7). Confusion regarding all of the 
above has probably resulted in a significant in-
crease in the request of vitamin D- related labora-
tory tests (8).
Our research hypothesis was that through educa-
tion and communication with the ordering clini-
cian we could improve appropriateness in the re-
quest vitamin D tests. The aim of this study is to 
show how education and communication from 
the clinical laboratory through comments in the 
Laboratory Information System (LIS), decreases the 
request of inappropriate tests and hence labora-
tory costs, promoting the correct use and self-reg-
ulation of laboratory tests demand in the study of 
vitamin D deficiency.
Materials and methods 
Setting 
The laboratory is located at the public University 
Hospital of San Juan (Alicante, Spain), a 370-bed 
suburban community hospital that serves a popu-
lation of 234 551 inhabitants, which provides in- 
and out-patient services (15% of the overall 2.5 
million tests per year), including nine different pri-
mary care centers. It receives samples from inpa-
tients, outpatients and primary care patients. From 
year 2010, laboratory requests are made electroni-
cally from the patient’s electronic medical record 
(PEMR) and the reports are automatically sent 
from the LIS to the PEMR. 25(OH)D and 1,25(OH)2D 
tests do not belong to any laboratory profile. Prior 
to 2010, the physical ordering request did not in-
clude such tests in the list; they had to be manual-
ly written in the form in a blank space. 25(OH)D 
concentration was measured using a Cobas c 711® 
(Roche Diagnostics) and 1,25(OH)2D was measured 
using a LIAISON® XL Analyzer (DiaSorin). Vitamin D 
testing was available throughout the period of the 
study.
In view of the increased demand of 1,25(OH)2D, a 
personalized attention was done to every request. 
From November 2011 when 1,25(OH)2D was not 
related to diagnosis or clinical question, a specific 
coded result was registered manually in the LIS af-
ter examining the appropriateness of the test. This 
coded result is a comment as follows: “Serum 
1,25(OH)2D does not reflect vitamin D reserves, and 
its measurement is not useful for monitoring vitamin 
D status. Serum 1,25(OH)2D is frequently either nor-
mal or even elevated in those patients with vitamin D 
deficiency, due to secondary hyperparathyroidism. 
Thus, 1,25(OH)2D measurement does not reflect vita-
min D status” and a 25(OH)D was measured in-
stead. 
Analysis
A retrospective observational cross-sectional 
study was conducted from January 2005 to De-
cember 2014. We counted the number of 
1,25(OH)2D tests that were requested and also 
those that were requested but not measured and 
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reported through the aforementioned comment, 
starting in November 2011. We calculated the total 
economic saving, taking into account the number 
of 1,25(OH)2D tests that were requested but not 
measured and the cost of reagent (12.5 € per 
1,25(OH)2D test). We also assessed the 25(OH)D 
workload, the number of test requests in a period 
of time.
Data was collected from the LIS using a software 
program based on Data Warehouse and On-Line 
Analytical Processing (OLAP) cube (Omnium by 
Roche Diagnostics_ SUNSET Technologies, Gero-
na, Spain). 
Data processing 
After collecting the data, we counted the annual 
number of test requests and the number of com-
ments inserted in the report. We calculated the 
percentage of comments related to 1,25(OH)2D 
tests and the percentage of 1,25(OH)2D requests 
related to 25(OH)D requests.
Statistical analysis
We compared the percentage of comments be-
tween the first complete year (2012) and the last 
post- intervention year (2014). We also compared 
the percentage of 1,25(OH)2D requests between 
pre-intervention (2005-2010) and post-interven-
tion (2011-2014) periods. Differences in the previ-
ously mentioned percentages between periods 
were tested with the Chi-square test using SPSS 
software. A two-sided P ≤ 0.05 rule was utilized as 
the criterion for rejecting the null hypothesis of no 
difference.
Results
Table 1 shows the annual number of 25(OH)D and 
1,25(OH)2D requests, 1,25(OH)2D reported through 
a comment and ratio 1,25(OH)2D/25(OH)D. The an-
nual number of 25(OH)D and 1,25(OH)2D requests 
are also shown in Figure 1. It also displays the num-
ber of comments that were included on the labo-
ratory report, starting on November 2011. 
Year 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
25(OH)D requests 427 630 730 1248 1461 1847 2060 2655 2956 3705
1,25(OH)2D requests 130 136 134 132 160 175 179 150 121 87
1,25(OH)2D reported through a 
comment 0 0 0 0 0 0 17 62 7 10
Ratio 1,25(OH)2D/25(OH)D (%) 30 22 18 11 11 9 9 6 4 2
Table 1. Number of 25(OH)D and 1,25(OH)2D requests, 1,25(OH)2 reported through a comment and ratio 1,25(OH)2D/25(OH)D.
Figure 1. Number of 25(OH)D and 1,25(OH)2D tests requests, 
and comments that were inserted to the reports when 
1,25(OH)2D was not appropriately requested. 
The strategy, of reviewing each 1,25(OH)D request, started on 
November 2011.





















































The request of 25(OH)D increased over time. How-
ever, after 2012 - when 62 comments were report-
ed to the requesting physicians - the number of 
1,25(OH)2D requests decreased when compared to 
year 2014 (P < 0.001). The number of comments on 
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the laboratory report significantly decreased be-
tween pre (2005-2010) and post-intervention 
(2011-2012) periods (P < 0.001), indicating that the 
ordering providers were aware of the guidelines 
and were not ordering 1,25(OH)2D to detect vita-
min D deficiency.
From an economic perspective, the strategies re-
sulted in a savings of 1200€.
Discussion
After the implementation of our strategy, the re-
quest of 1,25(OH)2D decreased over time. The re-
search highlights that education and communica-
tion, based on our knowledge and current evi-
dence, through consistent comments on the LIS, 
appropriately addressed test request inappropri-
ateness. 
Education and communication is crucial in every 
pre analytical step (9). In the phlebotomy proce-
dure, through education and communication, 
sample incidences can be diminished (10,11). Sam-
ple transportation can also be improved through 
education. Transport indicators such as delivery 
time are very important since early sample deliv-
ery favors sample stability and timeliness (12).
Strategies to manage test requesting to ensure ad-
equate utilization of needed tests and discourag-
ing unnecessary tests were recently reviewed (13). 
Of the most successful interventions in laboratory 
test utilization management are those that com-
bine various tools. Indeed for its maintenance over 
time computer-aided algorithms (14) are crucial, 
being education a key tool in the laboratory test 
utilization management toolbox (13).
Our results highlight that education and commu-
nication are also key in test requesting, the most 
important step of the total testing process (15). In 
fact, strategies for managing test appropriateness 
require ongoing re-education of clinicians regard-
ing test request. The study also shows that al-
though medical electronic records have improved 
the adequacy in test ordering, they could be harm-
ful for the appropriate request of some rare tests 
that previously were not printed on old paper 
forms.
Rising awareness about the potential link between 
vitamin D deficiency and adverse health outcomes 
has increased vitamin D testing. However it is very 
important to order the right vitamin D metabolite 
for each specific clinical indication.
Both clinician actions - test request and interpreta-
tion - are surrounded by a number of different ad-
ditional tasks that probably interfere with the 
choice of the right test and a correct result inter-
pretation. Accordingly, it is an important task for 
laboratory professionals to help the clinician in 
these key phases, to obtain an optimal test selec-
tion and interpretation. We only have to export 
our knowledge into strategies for a better utiliza-
tion of laboratory tests.
The research has some limitations. First, we do not 
have at our disposal diagnoses for all requested 
1,25(OH)2D. Another limitation is that the study 
economic savings may be underestimated. In fact 
we would never know how many additional 
1-25(OH)2D tests would have been requested if no 
intervention had occurred. Lastly, the calculated 
economic savings may not apply to other coun-
tries or settings, since our laboratory belongs to 
the Public Health Network, where reactive prices 
are very low. 
Communication through an educational codified 
comment using our LIS to report when 1,25(OH)2D 
request was not appropriate to the clinical query 
resulted in an improved request of vitamin D.
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